J9359 Injection lon tesirin-lpyl 0.075mg
J-Codes
Also known as: loncastuximab tesirin, Zynlonta
Injection of loncastuximab tesirin-lpyl, 0.075 milligram. An antibody-drug conjugate targeting CD19 for B-cell lymphoma.
Clinical Context
Used for relapsed/refractory diffuse large B-cell lymphoma. CD19-targeting antibody-drug conjugate with topoisomerase I inhibitor.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.